| Costa Rica | | |
New HIV infections (per 1000 uninfected population) | 0.34 (2020) [1/19countries] | | | Tuberculosis incidence (per 100,000 population) | 11.0 (2021) [9/38countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.0 (2020) [31/38countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 9.5 (2019) [29/38countries] | | |
|
| Costa Rica | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 188.7 (2020) [35/38countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 3.0 (2020) [36/38countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 3.7 (2020) [33/38countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 47.5 (2020) [35/38countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 11.7 (2020) [11/38countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 24.7 (2020) [36/38countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 8.2 (2020) [34/38countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.5 (2020) [25/38countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 3.4 (2020) [38/38countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.3 (2020) [27/38countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 6.4 (2020) [31/38countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.2 (2020) [36/38countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 6.1 (2020) [10/38countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 5.4 (2020) [37/38countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 15.6 (2020) [26/38countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.9 (2020) [36/38countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.4 (2020) [12/37countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 9.8 (2020) [29/38countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 0.9 (2020) [37/38countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.5 (2020) [33/38countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 4.0 (2020) [38/38countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 4.9 (2020) [36/38countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 56.6 (2020) [29/38countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 12.8 (2020) [5/38countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 4.1 (2020) [32/38countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 11.3 (2020) [11/38countries] | | |
|
| Costa Rica | | |
Suicide, age-standardized (per 100 000 population) | 7.62 (2019) [29/38countries] | | | Suicide - male, age-standardized (per 100 000 population) | 13.35 (2019) [25/38countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.93 (2019) [35/38countries] | | | Suicide - 15-24 years (per 100,000 population) | 11.01 (2019) [11/38countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 19.06 (2019) [6/38countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 2.63 (2019) [27/38countries] | | | Suicide - 25-34 years (per 100,000 population) | 10.01 (2019) [21/38countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 16.72 (2019) [19/38countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 3.11 (2019) [25/38countries] | | | Suicide - 35-44 years (per 100,000 population) | 10.52 (2019) [27/38countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 18.34 (2019) [24/38countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 2.66 (2019) [33/38countries] | | | Suicide - 45-54 years (per 100,000 population) | 11.79 (2019) [31/38countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 20.61 (2019) [29/38countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 3.24 (2019) [33/38countries] | | | Suicide - 55-64 years (per 100,000 population) | 10.62 (2019) [31/38countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 19.59 (2019) [30/38countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 2.05 (2019) [35/38countries] | | | Suicide - 65-74 years (per 100,000 population) | 4.94 (2019) [37/38countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 9.67 (2019) [37/38countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 0.58 (2019) [38/38countries] | | | Suicide - 75-84 years (per 100,000 population) | 4.92 (2019) [36/38countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 10.85 (2019) [35/38countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 0.00 (2019) [37/38countries] | | | Suicide - 85 years and over (per 100,000 population) | 3.90 (2019) [37/38countries] | | |
|
|